Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Diabetes Mellitus
Interventions
DEVICE

Finesse

Finesse Insulin Delivery Patch

DEVICE

Pen/Syringe (Usual injection device)

Pen/Syringe

Trial Locations (5)

48202

Henry Ford Health System, Detroit

55416

International Diabetes Center at Park Nicollet, Minneapolis

60611

Northwestern University, Chicago

75390

University of Texas Southwestern Medical Center, Dallas

94110

California Pacific Medical Center, San Francisco

Sponsors
All Listed Sponsors
collaborator

Nancy Bohannon, MD, Med. Corp.

UNKNOWN

collaborator

Henry Ford Health System

OTHER

collaborator

Northwestern University

OTHER

collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

International Diabetes Center at Park Nicollet

OTHER

lead

Calibra Medical, Inc.

INDUSTRY

NCT01073566 - Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections | Biotech Hunter | Biotech Hunter